A region of 35 kb containing the trace amine associate receptor 6 (TAAR6) gene is associated with schizophrenia in the Irish study of high-density schizophrenia families

Molecular Psychiatry

Volumn 12, Issue 9, 2007, Pages 842-853

  Vladimirov, V ^a,f   Thiselton, D L ^a   Kuo, P H ^a   McClay, J ^a   Fanous, A ^a,b,c   Wormley, B ^a   Vittum, J ^a   Ribble, R ^a   Moher, B ^a   Van Den Oord, E ^a   O'Neill, F A ^d   Walsh, D ^e   Kendler, K S ^a   Riley, B P ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^e HEALTH RESEARCH BOARD   (Ireland)

^f VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Association; Expression; Gene; Haplotype; Schizophrenia; Trace amine receptor

Indexed keywords

BIOLOGICAL MARKER; GENE PRODUCT; TRACE AMINE ASSOCIATE RECEPTOR 6; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DELUSION; FAMILY; GENETIC ASSOCIATION; GENOTYPE; HALLUCINATION; HAPLOTYPE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SCHIZOPHRENIA; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE;

CELL CYCLE PROTEINS; COMPUTATIONAL BIOLOGY; FAMILY HEALTH; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IRELAND; LINKAGE (GENETICS); MALE; MODELS, MOLECULAR; MOLECULAR WEIGHT; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA;

EID: 34548303922     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/sj.mp.4001984     Document Type: Article

References (56)

1. Jablensky A, Sartorius N, Ernberg G, Anker M, Korten A, Cooper JE et al. Schizophrenia: manifestations, incidence and course in different countries - a World Health Organization Ten Country Study. Psychol Med Monogr Suppl 1992; 20: 1-97.
2. Kendler KS, Gruenberg AM, Kinney DK. Independent diagnosis of adoptees and relatives as defined by DSM-III in the provincial and national samples of the Danish Adoption Study of Schizophrenia. Arch Gen Psychiatry 1994; 51: 456-468.
3. Kendler KS, Diehl SR. The genetics of schizophrenia: a current, genetic-epidemiologic perspective. Schizophr Bull 1993; 19: 261-285.
4. Duan J, Martinez M, Sanders AR, Hou C, Saitou N, Kitano T et al. Polymorphisms in the trace amine receptor 4 (TRAR4) gene on chromosome 6q23.2 are associated with susceptibility to schizophrenia. Am J Hum Genet 2004; 75: 624-638.
5. Lindemann L, Ebeling M, Kratochwil NA, Bunzow JR, Grandy DK, Hoener MC. Trace amine-associated receptors form structurally and functionally distinct subfamilies of novel G protein-coupled receptors. Genomics 2005; 85: 372-385.
6. Davis BA, Boulton BA. The trace amines and their acidic metabolites in depression - an overview. Prog Neuropsychopharmacol Biol Psychiatry 1994; 18: 17-45.
7. Sandler M, Ruthven CRJ, Goodwin BL, Coppen A. Decreased cerebrospinal fluid concentration of free phenylacetic acid in depressive illness. Clin Chim Acta 1979; 93: 169-171.
8. Potkin SG, Karoum F, Chuang LW, Cannon-Spoor HE, Phillips I, Wyatt RJ. Phenylethylamine in paranoid chronic schizophrenia. Science 1979; 206: 470-471.
9. Premont RT, Gainetdinov RR, Caron MG. Following the trace of elusive amines. Proc Natl Acad Sci USA 2001; 98: 9474-9475.
10. Borowsky B, Adham N, Jones KA, Raddatz R, Artymyshyn R, Ogozalek KL et al. Trace amines: identification of a family of mammalian G protein-coupled receptors. Proc Natl Acad Sci USA 2001; 98: 8966-8971.
11. Bunzow JR, Sonders MS, Arttamangkul S, Harrison LM, Zhang G, Quigley DI et al. Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. Mol Pharmacol 2001; 60: 1181-1188.
12. Grossberg S. The imbalanced brain: from normal behavior to schizophrenia. Biol Psychiatry 2000; 48: 81-98.
13. Kendler KS, O'Neill FA, Burke J, Murphy B, Duke F, Straub RE et al. Irish study on high-density schizophrenia families: field methods and power to detect linkage. Am J Med Genet 1996; 67: 179-190.
14. McGuffin P, Farmer A, Harvey I. A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system. Arch Gen Psychiatry 1991; 48: 764-770.
15. Torrey EF, Webster M, Knable M, Johnston N, Yolken RH. The Stanley Foundation brain collection and Neuropathology Consortium. Schizoph Res 2000; 44: 151-155.
16. van den Oord EJCG, Jiang Y, Riley BP, Kendler KS, Chen X. FP-TDI SNP scoring by manual and statistical procedures: a study of error rates and types. Biotechniques 2003; 34: 610-624.
17. Rozen S, Skaletsky HJ. Primer3 on the WWW for general users and for biologist programmers. In: Krawetz S, Misener S (eds). Bioinformatics Methods and Protocols: Methods in Molecular Biology. Humana Press: Totowa, NJ, 2000, pp 365-386.
18. Abecasis GR, Cherny SS, Cookson WO, Cardon LR. Merlin - rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 2002; 30: 97-101.
19. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265.
20. Excoffier L, Slatkin M. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 1995; 12: 921-927.
21. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B et al. The structure of haplotype blocks in the human genome. Science 2002; 296: 2225-2229.
22. Laird NM, Horvath S, Xu X. Implementing a unified approach to family-based tests of association. Genet Epidemiol Suppl 2000; 19: S36-S42.
23. Rabinowitz D, Laird N. An unified approach to adjusting association tests for population admixture with arbitrary pedigree structure and arbitrary missing marker information. Hum Hered 2000; 50: 211-223.
24. Martin ER, Monks SA, Warren LL, Kaplan NL. A test for linkage and association in general pedigrees: the pedigree disequilibrium test. Am J Hum Genet 2000; 67: 146-154.
25. Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Gen Epidemiology 2003; 25: 115-121.
26. Clayton D. A generalization of the transmission/disequilibrium test for uncertain haplotype transmission. Am J Hum Genet 1999; 65: 1170-1177.
27. Clayton D, Jones H. Transmission/disequlibrium tests for extended marker haplotypes. Am J Hum Genet 1999; 65: 1161-1169.
28. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quanti. Methods 2001; 25: 402-408.
29. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002; 3: RESEARCH0034.
30. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68: 978-989.
31. Stephens M, Donnelly PA. Comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003; 73: 1162-1169.
32. Couronne O, Poliakov A, Bray N, Ishkhanov T, Ryaboy D, Rubin E et al. Strategies and tools for whole-genome alignments. Genome Res 2003; 13: 73-80.
33. Mathews DH, Disney MD, Childs JL, Schroeder SJ, Zuker M, Turner DH. Incorporating chemical modification constraints into a dynamic programming algorithm for prediction of RNA secondary structure. Proc Natl Acad Sci USA 2004; 101: 7287-7292.
34. Mathews DH, Sabina J, Zuker M, Turner DH. Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure. J Mol Biology 1999; 288: 911-940.
35. Enright AJ, John B, Gaul U, Tuschl T, Sander C, Marks DS. MicroRNA targets in Drosophila. Genome Biol 2003; 5: R1.
36. Griffiths-Jones S. The microRNA registry. Nucleic Acids Res 2004; 32: D109-D111.
37. Fanous AH, van den Oord EJ, Riley BP, Aggen SH, Neale MC, O'Neill FA. Relationship between a high-risk haplotype in the DTNBP1 (Dysbindin) gene and clinical features of schizophrenia. Am J Psychiatry 2005; 162: 1824-1832.
38. Puga I, Lainez B, Fernandez-Real JM, Buxade M, Broch M, Vendrell J et al. A polymorphism in the 3′ untranslated region of the gene for tumor necrosis factor receptor 2 modulates reporter gene expression. Endocrinology 2005; 146: 2210-2220.
39. Conne B, Stutz A, Vassalli JD. The 3′ untranslated region of messenger RNA: a molecular 'hotspot' for pathology? Nat Med 2000; 6: 637-641.
40. Grün D, Wang Y-L, Langenberger D, Gunsalus KC, Rajewsky N. microRNA target predictions across seven Drosophila species and comparison to mammalian targets. PLoS Comput Biol 2005; 1: e13.
41. Branchek TA, Blackburn TP. Trace amine receptors as targets for novel therapeutics: legend, myth and fact. Curr Opin Pharmacol 2003; 3: 90-97.
42. Cao Q, Martinez M, Zhang J, Sanders AR, Badner JA, Cravchik A et al. Suggestive evidence for a schizophrenia susceptibility locus on chromosome 6q and a confirmation in an independent series of pedigrees. Genomics 1997; 43: 1-8.
43. Duan S, Du J, Xu Y, Xing Q, Wang H, Wu S et al. Failure to find association between TAAR6 and schizophrenia in the Chinese Han population. J Neural Transm 2005 [Advance online publication, August 3].
44. Ikeda M, Iwata N, Suzuki T, Kitajima T, Yamanouchi Y, Kinoshita Y et al. No association of haplotype-tagging SNPs in TAAR6 with schizophrenia in Japanese patients. Schizophr Res 2005; 78: 127-130.
45. Amann D, Avidan N, Kanyas K, Kohn Y, Hamdan A, Ben-Asher E et al. The trace amine receptor 4 gene is not associated with schizophrenia in a sample linked to chromosome 6q23. Mol Psychiatry 2005 Adv online publication, September 27.
46. Paciga SA, Fan Y-T, Walton KM, King DP. Identification of a haplotype in TAAR6 (TRAR4) associated with susceptibility to schizophrenia in a Caucasian population. The 55th Annual Meeting of the American Sociaty of Human Genetics. Salt Lake City, Utah, USA, October 25th-29th, 2005. Abstract book, p 316.
47. Jamra RA, Sircar I, Becker T, Freudenberg-Hua Y, Ohlraun S, Freudenberg J et al. A family-based and case-control association study of trace amine receptor genes on chromosome 6q23 in bipolar affective disorder. Mol Psychiatry 2005; 10: 618-620.
48. Neale BN, Sham PC. The future of association studies: gene-based analysis and replication. Am J Hum Genet 2004; 75: 353-362.
49. Nakajima T, Jorde LB, Ishigami T, Umemura S, Emi M, Lalouel J-M et al. Nucleotide diversity and haplotype structure of the human angiotensinogen gene in two populations. Am J Hum Genet 2002; 70: 108-123.
50. Hilgers V, Pourquié O, Dubrulle J. In vivo analysis of mRNA using the Tet-Off system in chicken embryo. Dev Biol 2005; 284: 292-300.
51. Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T. Identification of tissue-specific microRNAs from mouse. Curr Biol 2002; 12: 735-739.
52. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005; 120: 15-20.
53. Fanous AH, Kendler KS. Genetic heterogeneity, modifier genes, and quantitative phenotypes in psychiatric illness: searching for a framework. Mol Psychiatry 2005; 10: 6-13.
54. Finch CE, Sapolsky RM. The evolution of Alzheimer disease, the reproductive schedule, and apoE isoforms. Neurobiol Aging 1999; 20: 407-428.
55. Conrad C, Vianna C, Schultz C, Thal DR, Ghebremedhin E, Lenz J et al. Molecular evolution and genetics of the Saitohin gene and tau haplotype in Alzheimer's disease and argyrophilic grain disease. J Neurochem 2004; 89: 179-188.
56. Gregory SG, Barlow KF, McLay KE, Kaul R, Swarbreck D, Dunham A et al. The DNA sequence and biological annotation of human chromosome1. Nature 2006; 441: 315-321.